Functional assays, including wound healing and cell migration assays, were conducted across various cell types, including CD4+ T cells and cancer cells, to evaluate the impact of GPR15LG on CXCL12-mediated CXCR4 signaling. The gene discussed is CD4; the disease is cancer.